Thomas Jefferson University
Neurology
Dr. Stephen D. Silberstein, MD
|
|
Give Review
Stephen Silberstein is an expert in the field of Neurology. He researched medicine at Perelman School of Medicine at the University of Pennsylvania. He has 5 awards "Philadelphia Magazine", "America's Top Doctors", "Women's Health", "Men's Health" and "Super Doctor". Stephen Silberstein has written publications. He has 97 publications published with PubMed. The lastest publication is: 'Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Long-Term Pain Reduction Does Not Imply Improved Functional Outcome in Patients Treated With Combined Supraorbital and Occipital Nerve Stimulation for Chronic Migraine.
- Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II.
- Safety and efficacy of AMG 334 for prevention of episodic Migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
- Case Report: Secondary SUNCT After Radiation Therapy-A Novel Presentation.
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic Migraine: a multicentre, randomised, double-blind, placebo-controll...
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of Chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
- Episodic and Chronic migraine headache: breaking down barriers to optimal treatment and prevention.
- The acute treatment of migraine in adults: the american Headache society evidence assessment of migraine pharmacotherapies.
- Acute Migraine treatment.
- Per cent of patients with Chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT.
- Assessing Clinically Meaningful Treatment Effects in Controlled Trials: Chronic Migraine as an Example.
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic Migraine: a randomised, double-blind, placebo-co...
- Considerations in the Treatment of Tension-Type Headache in the Elderly.
- Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.
- Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment.
- COX inhibitors for the treatment of Migraine.
- Operational diagnostic criteria for Chronic migraine: expert opinion.
- Is the migraine Brain super-active?
- Headaches Caused by Nasal and Paranasal Sinus Disease.
- OnabotulinumtoxinA for Chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
- Comparing the Efficacy of Eletriptan for Migraine in Women During Menstrual and Non-Menstrual Time Periods: A Pooled Analysis of Randomized Controlled Trials.
- Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient Pain relief in a phase 3 study.
- Migraine Genetics: Part II.
- OnabotulinumtoxinA for treatment of Chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
- Psychiatric comorbidities of episodic and Chronic migraine.
- Sumatriptan : treatment across the full spectrum of Migraine.
- Migraine Genetics - A Review: Part I.
- Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from Pain.
- Dihydroergotamine: A Review of Formulation Approaches For the Acute Treatment of Migraine.
- Trigeminal Autonomic cephalalgias other than cluster headache.
- Use of common Migraine treatments in breast-feeding women: a summary of recommendations.
- Evidence-based guideline update: NSAIDs and other complementary treatments for episodic Migraine prevention in adults: Report of the Quality Standards Subcommittee of ...
- Expert Consensus Recommendations for the Performance of Peripheral Nerve Blocks for Headaches - A Narrative Review.
- Migraine triggers: Harnessing the messages of clinical practice.
- Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for Migraine prophylaxis.
- Emerging target-based paradigms to prevent and treat Migraine.
- MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of Migraine.
- Efficacy and Safety of MAP0004, Orally Inhaled DHE in Treating Migraines With and Without Allodynia.
- OnabotulinumtoxinA for treatment of Chronic migraine: a response.
- Targeting sleep disruption using sodium oxybate in Chronic cluster headache prophylaxis.
- MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of Migraine.
- Migraine in women with Chronic pelvic pain with and without endometriosis.
- Current understanding and treatment of headache Disorders: five new things.
- Defining the pharmacologically intractable Headache for clinical trials and clinical practice.
- Method of injection of onabotulinumtoxinA for Chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
- Meeting acute Migraine treatment needs through novel treatment formulations.
- 14th International Headache Congress: clinical highlights.
- Acetate causes alcohol hangover Headache in rats.
- Headache prophylaxis with BoNTA: patient characteristics.
- Scheduled short-term prevention with frovatriptan for Migraine occurring exclusively in association with menstruation.
- Preventive Migraine treatment.
- Intravenous lidocaine in the treatment of refractory Headache: a retrospective case series.
- Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.
- Intravenous lidocaine infusion for the treatment of post-acoustic neuroma resection Headache: a case report.
- Menstrual migraine: case studies of women with estrogen-related Headaches.
- Diagnosis and treatment of the Menstrual migraine patient.
- The Headache management trial: a randomized study of coordinated care.
- Triptans: actions and reactions.
- Menstrually related migraine: breaking the cycle in your clinical practice.
- Less is not more: underutilization of Headache medications in a university hospital emergency department.
- Dihydroergotamine for early and late treatment of Migraine with cutaneous allodynia: an open-label pilot trial.
- Efficacy of eletriptan in Migraine-related functional impairment: functional and work productivity outcomes.
- Pharmacological approaches to managing Migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.
- Topiramate in Migraine prophylaxis: long-term impact on resource utilization and cost.
- Impact of topiramate Migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials.
- Hemicrania continua-like headache associated with internal carotid Artery dissection may respond to indomethacin.
- Migrainous visual auras: a life history.
- Efficacy and tolerability of topiramate 200 mg/d in the prevention of Migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pil...
- Acute Migraine treatment: patterns of use and satisfaction in a clinical population.
- Combination therapy in acute Migraine treatment: the rationale behind the current treatment options.
- Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute Migraine: results from a multicenter, double-blind, randomized, parallel-group, single-d...
- Cervical epidural blood patch for low CSF pressure Headaches.
- Removing barriers to appropriate Migraine treatment: formulary limitations and triptan package size.
- Burden of illness and satisfaction with care among patients with Headache seen in a primary care setting.
- Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of Migraine: results from the ASSET trial.
- The Headache of SAH responds to sumatriptan.
- Topiramate in Migraine prevention.
- Chronic daily headache.
- Neuroleptics in Headache.
- Topiramate monotherapy in Epilepsy and migraine prevention.
- MRI of a Brain under pressure.
- Headaches in pregnancy.
- Migraine.
- Headache management for the pain specialist.
- A randomized trial of frovatriptan for the intermittent prevention of Menstrual migraine.
- Study of mitochondrial DNA mutations in patients with Migraine with prolonged aura.
- Anticonvulsants in Migraine.
- Botulinum neurotoxin for the treatment of migraine and other primary headache Disorders.
- Headaches due to nasal and paranasal sinus Disease.
- Efficacy and tolerability of oral zolmitriptan in Menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
- Botulinum toxin and other new approaches to Migraine therapy.
- Productivity cost benefit to employers of treating Migraine with rizatriptan: a specific worksite analysis and model.
- Chronic migraine: diagnosis and management strategy.
- The prevalence of Migraine in neurologists.
- Procedures for administering botulinum toxin type A for migraine and tension-type Headache.
- Neurotoxins in the neurobiology of Pain.
Schools
University Of Pennsylvania School Of Medicine
Hospital Of The University Of Pennsylvania
National Institute Of Health
Procedures Preformed
- Nerve Block, Somatic
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- Women's Health
- Men's Health
- Super Doctor
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Thomas Jefferson University Hospital
Drug Facts
| NPI NUMBER | 1881617413 | |
| NPPES Provider LastName | SILBERSTEIN | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 191075509 | |
| NPPES Provider State | PA | |
| Specialty Description | Neurology | |
| Total Claim Count | 1271.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1881617413 |
| Last Name Of The Provider | SILBERSTEIN |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
Dr. Jeffrey I. Greenstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susanna Pantelyat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rima Alkasem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald H. Silberberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Francisco A. Gonzalez-Scarano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anjan K. Chatterjee, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott E. Mintzer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vijayta G. Bansal-Kapuria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca N. Ichord, MD
This Doctor is OpenDoctor Recommended.
|